Cited by 680Genomics, phytochemicals, and oxidative stressGlutathione Transferases and PolymorphismsRedox biology and oxidative stress

Toward clinical application of the Keap1-Nrf2 pathway

Suzuki, Takafumi, Motohashi, Hozumi, Yamamoto, Masayuki·2013·Trends in Pharmacological Sciences

Abstract

The Keap1-Nrf2 pathway plays a crucial role in determining the sensitivity of cells to chemical and/or oxidative insults by regulating the basal and inducible expression of detoxification and antioxidant enzymes, ABC transporters, and other stress response enzymes and/or proteins. Increasing attention has been focused on the roles that the Keap1-Nrf2 pathway plays in the protection of our body against drug toxicity and stress-induced diseases. Simultaneously, Nrf2 has been recognized to promote oncogenesis and resistance to chemotherapeutic drugs. Cancer cells hijack Nrf2 activity to support their malignant growth and thus Nrf2 has emerged as a therapeutic target. Translational studies of the Keap1-Nrf2 system, from mechanistic understanding to clinical applications, are now important to improve human health.

Integrity signals

Registry

Crossref · 10.1016/j.tips.2013.04.005

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The importance of Nrf2 in the protection against human diseases is well established, and much research has explored the use of Nrf2 activators in the treatment of disease.

    “The importance of Nrf2 in the protection against human diseases is well established and much research has explored the use of Nrf2 activators in the treatment of disease [220,221,222,223].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Suzuki, T., Motohashi, H., & Yamamoto, M.
Affiliations
Tohoku University (JP)
Corresponding author
Yamamoto, Masayuki
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2013-06
Volume
34
Issue
6
Pages
340-346
ISSN
0165-6147 (ISSN-L)
OpenAlex
W2017498511
Cited by
680
References
60
Citations by year
2026: 25 · 2025: 43 · 2024: 39 · 2023: 42 · 2022: 55 · 2021: 51 · 2020: 74 · 2019: 58 · 2018: 59 · 2017: 55 · 2016: 61 · 2015: 77 · 2014: 36 · 2013: 4 · 2012: 1
FWCI
5.67
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in Pharmacological Sciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Tohoku University
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Science and Technology Agency
  • Naito Foundation
  • Japan Society for the Promotion of Science
  • Core Research for Evolutional Science and Technology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
Nrf2/Keap1 pathway, Nrf2, oxidative stress response, detoxification enzymes, antioxidant enzymes, ABC transporters, drug toxicity, chemoresistance, cancer, carcinogenesis, therapeutic target, clinical application
MeSH terms
Kelch-Like ECH-Associated Protein 1, Animals, Antineoplastic Agents, Cell Transformation, Neoplastic, Humans, Oxidative Stress, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review